COVID-19患者静脉血栓栓塞症的预防、诊断与治疗:CHEST指南与专家组报告
该指南由CHEST专家组针对COVID-19患者VTE的预防、诊断与治疗制定。专家组以PICO格式提出13个临床问题,系统检索MEDLINE、Embase和Cochrane对照试验注册库,采用经验证的工具分级证据,证据不足时以改良德尔菲法达成共识。最终形成22条推荐意见。
要点
- COVID-19重症可合并显著凝血异常,可能表现为微血栓形成和VTE。
- 围绕13个PICO问题形成22条关于VTE预防、诊断和治疗的推荐意见。
- COVID-19人群直接证据很少,多数意见基于专家共识和既有循证指南。
核心结论
- COVID-19患者VTE预防、诊断和治疗的最佳策略证据稀少但快速演变。
- 专家组基于有限证据与专家共识形成了22条指导性推荐意见。
研究设计与样本
- CHEST指南与专家组报告,围绕13个PICO格式临床问题展开。
- 系统检索MEDLINE(经PubMed或Ovid)、Embase和Cochrane对照试验注册库,并筛查参考文献。
- 采用经验证的评价工具对支持每条推荐意见的证据水平进行分级。
- 证据不存在时,采用改良德尔菲法以共识方式制定指导意见。
主要发现
- 系统综述与文献批判性分析基于13个PICO问题,共形成22条陈述。
- COVID-19人群中现有证据非常少。
- 专家组因此采用专家共识和既有循证指南来制定指导意见。
关键数值与推荐
- 围绕13个PICO问题形成22条推荐意见,涉及VTE的预防、诊断与治疗。
- 证据不足时以改良德尔菲法共识作为推荐依据。
临床怎么用
- 可依据该指南的22条意见,对COVID-19患者进行VTE的预防、诊断和治疗决策。
- 在直接证据缺乏时,可参考专家组基于共识和既有循证指南给出的指导意见。
局限性
- COVID-19人群中关于VTE预防、诊断和治疗 optimal 策略的证据非常少。
- 相关证据稀少但快速演变,指南意见需随新证据更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of VTE. METHODS: A group of approved panelists developed key clinical questions by using the PICO (Population, Intervention, Comparator, Outcome) format that addressed urgent clinical questions regarding the prevention, diagnosis, and treatment of VTE in patients with COVID-19. MEDLINE (via PubMed or Ovid), Embase, and Cochrane Controlled Register of Trials were systematically searched for relevant literature, and references were screened for inclusion. Validated evaluation tools were used to grade the level of evidence to support each recommendation. When evidence did not exist, guidance was developed based on consensus using the modified Delphi process. RESULTS: The systematic review and critical analysis of the literature based on 13 Population, Intervention, Comparator, Outcome questions resulted in 22 statements. Very little evidence exists in the COVID-19 population. The panel thus used expert consensus and existing evidence-based guidelines to craft the guidance statements. CONCLUSIONS: The evidence on the optimal strategies to prevent, diagnose, and treat VTE in patients with COVID-19 is sparse but rapidly evolving.
引用
- Moores LK, Tritschler T, Brosnahan S, et al. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest. 2020. PMID: 32502594. doi:10.1016/j.chest.2020.05.559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。